Send me a link:

*Text messaging rates may apply.

 Dow Up 0.14% Nasdaq Up 0.31%

CytRx Corporation (CYTR)

-NasdaqCM
3.40 Down 0.03(0.85%) 1:05PM EDT - Nasdaq Real Time Price
Prev Close:3.43
Open:3.45
Bid:3.40 x 3700
Ask:3.41 x 500
1y Target Est:11.00
Beta:1.37
Next Earnings Date:N/A
Day's Range:3.36 - 3.50
52wk Range:2.00 - 8.35
Volume:317,356
Avg Vol (3m):1,630,710
Market Cap:189.69M
P/E (ttm):N/A
EPS (ttm):-0.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTR

Comparison

Symbol% ChgMkt Cap
CYTRDown 0.85%189.69M
LLYDown 0.54%67.86B
NVSUp 0.59%214.21B
SNYUp 1.02%136.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):637.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.56
Quarterly EPS Est (Jun-14) :-0.20
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback